Genevieve Crane, Associate Professor of Pathology at Case Western Reserve University School of Medicine, shared on X about a recent paper byAna Romina Montivero et al. published in American Journal of Hematology:
“An adult patient with Lymphocytic Variant Hypereosinophilic Syndrome with extensive mucocutaneous involvement was successfully treated with ruxolitinib, highlighting the role of JAK-STAT signaling in this pathology and the flow cytometry in the diagnosis.”
Title: Lymphocytic Variant Hypereosinophilic Syndrome With Extensive Mucocutaneous Involvement Successfully Treated With Ruxolitinib
Authors: Ana Romina Montivero, Camila Anderlini, Gabriela Luque, María Belén Fiora, Marco Mazzotta, Mónica Freiberg, Enrique Valente, María Kurpis, Ana Lisa Basquiera
